Patient access to cardiovascular devices delayed by bureaucracy
Companies reducing R&D spend due to reimbursement stalls
2015-07-02
(Press-News.org) Sophia Antipolis, 02 July 2015: Patients are experiencing significant delays in access to approved cardiovascular devices due to bureaucratic inefficiencies, reveals a Devices White Paper from the Cardiovascular Round Table (CRT) published today in European Heart Journal.1
There is a clear correlation between declining death rates from cardiovascular disease and the introduction of innovative techniques and devices.1
The CRT is an independent forum established by the European Society of Cardiology (ESC) and comprised of cardiologists and representatives of the pharmaceutical, device and equipment industries.
ESC President Professor Fausto Pinto, lead author and CRT member, said: "These devices are safe, approved by regulators and included in guidelines but inclusion in reimbursement systems lags behind. Patients may therefore have delayed access to recommended treatments because of bureaucratic delays. The knock-on effect is that return on investment is reduced and companies are scaling back R&D investment for future device therapies."
He continued: "Innovation in cardiovascular devices is desperately needed to halt an epidemic of cardiovascular disease. Cardiovascular disease is the leading cause of death in Europe but an ageing population plus rapid growth of diabetes and obesity is pushing us towards an even greater problem. Research suggests that 40% of the population will have at least one form of cardiovascular disease by 2030. Novel devices are needed but inefficient DRG systems are putting development at risk."
The authors state: "Device manufacturers are concerned that their ability to invest in future R&D programmes will be limited by the unintentional side effect of inefficient processes within DRG systems. Manufacturers are already reporting a significant shortfall in the forecast utilisation of the current generation of cardiovascular devices even when there is clear demand, regulatory approval has been obtained, clinical efficacy has been proven, and the techniques are included within formal guidelines."
Under the diagnosis related group (DRG) system cases are categorised into diagnosis groups. Hospitals claim a standard tariff for each inpatient stay against the code for a treatment. When a new device is developed a code has to be raised so that it can be reimbursed. Prior to this, devices are awarded a CE Mark which certifies proven safety and performance. Individual countries then carry out a health technology assessment (HTA) which again evaluates safety and clinical effectiveness. Assigning a reimbursement code nationally should be purely an administrative step but can take six years or more. The heterogeneity and need for repeated HTA assessment in various European countries could also represent another limiting step in the introduction of clinically proven technologies.
"It is inefficiencies in allocating this code number for the current generation of cardiovascular devices that, surprisingly, represents a major threat to investment in the next generation," warn the authors.
The paper provides examples of innovative device technologies that are underused due to inefficiencies in reimbursement, such as transcatheter aortic valve implantation (TAVI) and fractional flow reserve (FFR).
The authors recommend ways to bring innovation to clinical practice sooner and make investment more attractive. These include:
Establish a working group of EU and national regulatory authorities and HTA agencies, medical professional societies and industry trade associations to speed up clinical adoption of new devices after approval
National cardiac societies to engage with reimbursement agencies and HTA agencies to create target timescales for allocation of reimbursement codes and agree a process for interim funding of promising new techniques
Professor Pinto said: "Research has shown a clear correlation between declining death rates from cardiovascular disease and the introduction of novel techniques and devices. However, reimbursement systems in Europe are blunting cardiovascular innovation. Now is the time for regulators, HTA agencies, professional societies, industry and national cardiac societies to speed up clinical adoption of new devices so that patients receive the best treatments now and in the future."
INFORMATION:
References
1Barriers to cardiovascular device innovation in Europe. European Heart Journal. 2015; doi:10.1093/eurheartj/ehv275
ELSE PRESS RELEASES FROM THIS DATE:
2015-07-02
Birds that moult at the wrong time of the year could be disadvantaged, according to a study by scientists at Lund University, Sweden. Birds depend on a full set of feathers for maximum efficiency when flying long distances, but the study shows that moulting has a detrimental effect on their flight performance.
The researchers trained a jackdaw to fly in a wind tunnel and measured different types of drag experienced by the bird. "We expected the bird not to be able to glide at the lowest speeds that it could glide at before moult and our results confirmed this", says ...
2015-07-02
Children with Attention Deficit Hyperactivity Disorder (ADHD) may be successfully supported in classrooms through strategies that do not involve drugs, new research has indicated. These children are typically restless, act without thinking and struggle to concentrate, which causes particular problems for them and for others in school.
A systematic review was led by the University of Exeter Medical School funded by NIHR's Health Research Technology Assessment programme and supported by the NIHR Collaboration for Leadership in Applied Health Research and Care South West ...
2015-07-02
Being able to dive is what matters most for seal pups, but how do they learn to do it? Grey seal pups that can play in pools may have better diving skills once they make the move to the sea, and this could increase their chance of survival. Researchers at Plymouth University have found that spending time in pools of water helps seal pups hold their breath for longer.
Many seal species stay on land after they have weaned before they go to sea to feed for the first time. "It is during this period of fasting that access to water can make a difference to diving ability," ...
2015-07-02
New guidelines for diagnosing chronic lung disease (chronic obstructive pulmonary disease or COPD), should be modified because they over-diagnose COPD in older men and under-diagnose COPD in young women.
Writing in The BMJ this week, Professor Martin Miller and Dr Mark Levy say up to 13% of people thought to have COPD under the new criteria have been found to be misdiagnosed.
They argue that clinicians should use internationally agreed standards when assessing patients for COPD. This, they say, will help to improve patient care through more accurate diagnosis, as well ...
2015-07-02
Evidence is lacking that having a category of drugs that can be sold only by pharmacists or under their supervision ("pharmacy medicines") has benefits, writes a pharmacy professor in The BMJ this week.
Professor Paul Rutter at the School of Pharmacy, University of Wolverhampton, calls for an end to pharmacists' monopoly on selling some drugs and thinks that a two tier system of prescription or non-prescription drugs, like in the US, would be simpler.
He mentions the recent case of the painkiller, oral diclofenac, that used to be available as a non-prescription drug ...
2015-07-02
Diabetes research is dominated by a small group of prolific authors, raising questions about the imbalance of power and conflict of interests in this field, argue experts in The BMJ this week.
In a new study, Frits Holleman and colleagues searched PubMed for all randomised controlled studies (RCTs) on glucose lowering treatments for diabetes from 1993 to 2013.
In total, they identified 3,782 articles with 13,592 authors.
The top 110 authors were named in a third (32.4%) of all articles, and they authored 991 RCTs, equivalent to 20 RCTs per author.
Of these 110 ...
2015-07-02
Philadelphia -- Elias S. Siraj, M.D., FACP, FACE, director of the Diabetes Program at Temple University Hospital (TUH), and Kevin J. Williams, M.D., FACP, chief of endocrinology, diabetes and metabolism at TUH, co-authored an editorial piece published July 2 in the New England Journal of Medicine about a major weight loss study involving obese and overweight patients.
Siraj and Williams offered their take on the significance of the randomized, double-blind clinical trial that showed a daily injection of 3.0 mg of the drug liraglutide, when given as an adjunct to diet ...
2015-07-02
Scientists have identified a group of genetic mutations in patients with aplastic anemia, which likely will help doctors optimize treatment for this rare and deadly blood condition. The study, appearing in the New England Journal of Medicine, could lead to tailor-made treatment plans for aplastic anemia patients as part of the emerging precision medicine movement. It is the largest study of its kind to examine gene mutations in aplastic anemia, the scientists note.
The work involved researchers from the National Institutes of Health, the Cleveland Clinic, Cleveland, ...
2015-07-01
DALLAS, July 1, 2015 -- While menopause is commonly considered a risk factor for heart disease, menopausal women had a lower risk of dying from heart attack than men; however, this difference was less pronounced among blacks, according to research in the Journal of the American Heart Association.
In the first study to compare men and women and how menopause types impact risk of heart attack, researchers studied 23,086 black and white adults over age 45 and found:
White women who had surgical-induced menopause had a 35 percent reduced risk of non-fatal heart attacks ...
2015-07-01
As we walk along a forest path, the soil beneath our feet seems like a uniform substance. However, it is an intricate network of soil particles, pores, minerals, soil microbes, and more. It is awash in variety.
Soil is a living, dynamic substance, and the microbial life within it is crucial to providing plant life with the food they need to grow. The microbes can be bacteria or fungi, but both need space--the pores--for a good living environment.
Soil particles that clump together are aggregates. These are the architectural building blocks of soil. Their presence ...
LAST 30 PRESS RELEASES:
[Press-News.org] Patient access to cardiovascular devices delayed by bureaucracy
Companies reducing R&D spend due to reimbursement stalls
